Associated Papers
Epigenetic, Genetic, and Functional Germline Alterations of PAX Genes in Human Pathology: A Comprehensive Update.
Gomez VL et al.
Current Issues in Molecular Biology, 2026
Leveraging genomic diagnostics for prognostics and therapeutics in pediatric acute leukemia.
Newman H et al.
Hemasphere, 2025
IGH::IL3-Rearranged B-Cell Precursor Acute Lymphoblastic Leukemia With Hypereosinophilia in a Child With a Novel PAX5 Germline Variant.
Urbański B et al.
Genes, Chromosomes & Cancer, 2025
A Comprehensive Review of Somatic and Germline Biomarkers Associated with Childhood B-Cell Precursor Acute Lymphoblastic Leukemia: From Biological Significance to Precision Medicine Opportunities.
Martínez Anaya D et al.
Biomedicines, 2025
Overt and covert genetic causes of pediatric acute lymphoblastic leukemia.
Stoltze U et al.
Leukemia, 2025
Copy number alterations in pediatric B-cell precursor acute lymphoblastic leukemia patients and their association with patients' outcome.
Abdelfattah NE et al.
Annals of Hematology, 2025
An evaluation of genetic predisposition to congenital anomalies and pediatric cancer supports KAT6B as a novel neuroblastoma susceptibility gene.
Gu H et al.
Genetics in Medicine Open, 2025
Unraveling the Genetic Heterogeneity of Acute Lymphoblastic Leukemia Based on NGS Applications.
Ramírez Maldonado V et al.
Cancers, 2024
Diverse mechanisms of leukemogenesis associated with PAX5 germline mutation.
Bettini LR et al.
Leukemia, 2024
Genomic Determinants of Outcome in Acute Lymphoblastic Leukemia.
Chang TC et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, 2024
Case report: A familial B-acute lymphoblastic leukemia associated with a new germline pathogenic variant in PAX5. The first report in Mexico.
García-Solorio J et al.
Frontiers in Oncology, 2024
A novel germline PAX5 single exon deletion in a pediatric patient with precursor B-cell leukemia.
van Engelen N et al.
Leukemia, 2023
Diagnostic utility of whole genome sequencing in adults with B-other acute lymphoblastic leukemia.
Leongamornlert D et al.
Blood Advances, 2023
Integrative genomic analysis of childhood acute lymphoblastic leukaemia lacking a genetic biomarker in the UKALL2003 clinical trial.
Schwab C et al.
Leukemia, 2023
Transcription factor genetics and biology in predisposition to bone marrow failure and hematological malignancy.
Zerella JR et al.
Frontiers in Oncology, 2023
Clinical and immunophenotypic characteristics of familial leukemia predisposition caused by PAX5 germline variants.
Escudero A et al.
Leukemia, 2022
Genetic Biomarkers and Their Clinical Implications in B-Cell Acute Lymphoblastic Leukemia in Children.
Lejman M et al.
International Journal of Molecular Sciences, 2022
PAX5 alterations in B-cell acute lymphoblastic leukemia.
Jia Z et al.
Frontiers in Oncology, 2022
Molecular Genetics of Pre-B Acute Lymphoblastic Leukemia Sister Cell Lines during Disease Progression.
Quentmeier H et al.
Current Issues in Molecular Biology, 2021
Application of Next-Generation Sequencing-Based Mutational Profiling in Acute Lymphoblastic Leukemia.
Aleem A et al.
Current Hematologic Malignancy Reports, 2021
Emerging molecular subtypes and therapeutic targets in B-cell precursor acute lymphoblastic leukemia.
Li J et al.
Frontiers of Medicine, 2021
A model combining clinical and genomic factors to predict response to PD-1/PD-L1 blockade in advanced urothelial carcinoma.
Nassar AH et al.
British Journal of Cancer, 2020
PAX5 biallelic genomic alterations define a novel subgroup of B-cell precursor acute lymphoblastic leukemia.
Bastian L et al.
Leukemia, 2019
PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia.
Gu Z et al.
Nature Genetics, 2019
Targeted next generation sequencing in Chinese colorectal cancer patients guided anti-EGFR treatment and facilitated precision cancer medicine.
Hou H et al.
Oncotarget, 2017
One missense mutation in exon 2 of the PAX5 gene in Iran.
Yazdanparast S et al.
Genetics and Molecular Research : Gmr, 2015